Avantor Investor Conference Presentation Deck
Reconciliations of GAAP to non-GAAP measures (continued)
Full Year 2020
$0.09
0.09
(Shares in M)
Diluted (loss) earnings per share (GAAP)
Dilutive impact of convertible instruments
Normalization for shares issued in IPO
Fully diluted (loss) earnings per share (non-GAAP)
Amortization
Net foreign currency loss (gain) from financing activities
Other stock-based compensation expense (benefit)
Loss on extinguishment of debt
Restructuring and severance charges
Acquisition-related expenses
Purchase accounting adjustments
Transaction, integration and planning expenses
Other
Receipt of disgorgement penalty
Adjustment for U.S. tax reform act
Income tax benefit applicable to pretax adjustments
Adjusted EPS (non-GAAP)
Weighted average share count (GAAP)
Share count for Adjusted EPS (non-GAAP)
Navantor™
Full Year 2018
$(2.69)
2.35
0.21
(0.13)
0.50
0.01
0.13
(0.01)
0.06
(0.04)
(0.16)
$0.36
133
643
Full Year 2019
$(0.84)
0.19
0.71
0.06
0.49
0.06
0.11
0.04
(0.02)
0.03
0.01
(0.20)
$0.58
401
643
0.18
0.48
0.54
0.01
0.02
0.01
(0.35)
$0.89
583
643
9 months ended 9/30/2021
$0.73
0.01
0.74
0.33
0.01
0.02
0.04
0.01
0.02
(0.02)
(0.09)
$1.06
593.0
643
40th Annual J.P. Morgan Healthcare Conference
25View entire presentation